4′-fluorocannabidiol associated with capsazepine restrains L-DOPA-induced dyskinesia in hemiparkinsonian mice: contribution of anti-inflammatory and anti-glutamatergic mechanisms (2024)
- Authors:
- USP affiliated authors: PEREIRA, MAURÍCIO DOS SANTOS - FMRP ; GUIMARÃES, FRANCISCO SILVEIRA - FMRP ; GUIMARAES, ELAINE APARECIDA DEL BEL BELLUZ - FORP ; VANDERLEI, LEONARDO CALAÇA ARRUDA - FMRP
- Unidades: FMRP; FORP
- DOI: 10.1016/j.neuropharm.2024.109926
- Subjects: ANTI-INFLAMATÓRIOS; CANABINOIDES; ANIMAIS DE LABORATÓRIO; DOENÇA DE PARKINSON; GLUTAMATOS
- Keywords: CB1; CB2; Glutamate; HU-910; Neuroinflammation; Parkinson's disease
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Neuropharmacology
- ISSN: 0028-3908
- Volume/Número/Paginação/Ano: v. 251, art. 109926, [15] p, 2024
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão submetida (Pré-print)
- Acessar versão aberta:
-
ABNT
PEREIRA, Maurício dos Santos et al. 4′-fluorocannabidiol associated with capsazepine restrains L-DOPA-induced dyskinesia in hemiparkinsonian mice: contribution of anti-inflammatory and anti-glutamatergic mechanisms. Neuropharmacology, v. 251, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2024.109926. Acesso em: 01 abr. 2026. -
APA
Pereira, M. dos S., Abreu, G. H. D. de, Vanderlei, L. C. A., Raisman-Vozari, R., Guimarães, F. S., Lu, H. -C., et al. (2024). 4′-fluorocannabidiol associated with capsazepine restrains L-DOPA-induced dyskinesia in hemiparkinsonian mice: contribution of anti-inflammatory and anti-glutamatergic mechanisms. Neuropharmacology, 251. doi:10.1016/j.neuropharm.2024.109926 -
NLM
Pereira M dos S, Abreu GHD de, Vanderlei LCA, Raisman-Vozari R, Guimarães FS, Lu H-C, Michel PP, Del Bel EA. 4′-fluorocannabidiol associated with capsazepine restrains L-DOPA-induced dyskinesia in hemiparkinsonian mice: contribution of anti-inflammatory and anti-glutamatergic mechanisms [Internet]. Neuropharmacology. 2024 ; 251[citado 2026 abr. 01 ] Available from: https://doi.org/10.1016/j.neuropharm.2024.109926 -
Vancouver
Pereira M dos S, Abreu GHD de, Vanderlei LCA, Raisman-Vozari R, Guimarães FS, Lu H-C, Michel PP, Del Bel EA. 4′-fluorocannabidiol associated with capsazepine restrains L-DOPA-induced dyskinesia in hemiparkinsonian mice: contribution of anti-inflammatory and anti-glutamatergic mechanisms [Internet]. Neuropharmacology. 2024 ; 251[citado 2026 abr. 01 ] Available from: https://doi.org/10.1016/j.neuropharm.2024.109926 - Cannabidiol prevents LPS-induced microglial inflammation by inhibiting ROS/NF-κB-dependent signaling and glucose consumption
- Contributive role of TNF-α to L-DOPA-induced dyskinesia in a unilateral 6-OHDA lesion model of Parkinson's disease
- CMT-3 targets different α-synuclein aggregates mitigating their toxic and inflammogenic effects
- Contributive role of TNF-α to L-DOPA-induced dyskinesia in a unilateral 6-OHDA lesion model of parkinson’s disease
- The chemically-modified tetracycline COL-3 and its parent compound doxycycline prevent microglial inflammatory responses by reducing glucose-mediated oxidative stress
- Rifampicin and its derivative Rifampicin quinone reduce microglial inflammatory responses and neurodegeneration induced in vitro by α-Synuclein fibrillary aggregates
- The two synthetic cannabinoid compounds 4′-F-CBD and HU-910 efficiently restrain inflammatory responses of brain microglia and astrocytes
- Cannabidiol and cannabinoid compounds as potential strategies for treating Parkinson’s disease and l-DOPA-induced dyskinesia
- Caracterização das células NG2-glia durante o curso temporal de lesão nigroestriatal dopaminérgica em camundongos hemiparkinsonianos
- The role of nitric oxide in salivary gland hypertrophy induced by isoproterenol
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
